Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue

Tissue Engineering - Part A

Volumn 16, Issue 4, 2010, Pages 1263-1270

  Kimura, Yu ^a   Miyazaki, Nobuhiko ^a   Hayashi, Naoki ^a   Otsuru, Satoru ^b   Tamai, Katsuto ^b   Kaneda, Yasufumi ^b   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; EMPLOYMENT; FLUORESCENCE; HYDROGELS; PROTEINS;

BLOOD CIRCULATION; BONE MARROW; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE; CONCENTRATION OF; CONTROLLED RELEASE; ENHANCED GREEN FLUORESCENT PROTEIN; GELATIN HYDROGELS; GREEN FLUORESCENT PROTEIN; OSTEOBLAST PROGENITORS; OSTEOCALCIN; OSTEOGENIC; OSTEOGENIC POTENTIAL; PROGENITOR CELL; RELEASE PROFILES;

BONE;

MUS;

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; GELATIN; GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN;

ADULT STEM CELL; ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; C57BL MOUSE; CELL MOTION; CYTOLOGY; DELAYED RELEASE FORMULATION; DRUG EFFECT; DRUG IMPLANT; EVALUATION; GENETICS; HUMAN; HYDROGEL; IN VITRO STUDY; MALE; METHODOLOGY; MOUSE; OSTEOBLAST; PHYSIOLOGY; TISSUE ENGINEERING; TRANSGENIC MOUSE;

ADULT STEM CELLS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL MOVEMENT; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; GELATIN; GREEN FLUORESCENT PROTEINS; HUMANS; HYDROGELS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOGENESIS; RECOMBINANT PROTEINS; TISSUE ENGINEERING;

EID: 77950814576     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0322     Document Type: Article

References (37)

1. Langer, R. Tissue engineering: perspectives, challenges, and future directions. Tissue Eng 13, 1, 2007.
2. Morrison, S.J., and Spradling, A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132, 598, 2008.
3. Ingber, D.E., Mow, V.C., Butler, D., Niklason, L., Huard, J., Mao, J., Yannas, I., Kaplan, D., and Vunjak-Novakovic, G. Tissue engineering and developmental biology: going biomimetic. Tissue Eng 12, 3265, 2006.
4. Matsumoto, T., and Mooney, D.J. Cell instructive polymers. Adv Biochem Eng Biotechnol 102, 113, 2006.
5. Badylak, S.F. The extracellular matrix as a biologic scaffold material. Biomaterials 28, 3587, 2007.
6. Ceradini, D.J., Kulkarni, A.R., Callaghan, M.J., Tepper, O.M., Bastidas, N., Kleinman, M.E., Capla, J.M., Galiano, R.D., Levine, J.P., and Gurtner, G.C. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10, 858, 2004.
7. Eghbali-Fatourechi, G.Z., Lamsam, J., Fraser, D., Nagel, D., Riggs, B.L., and Khosla, S. Circulating osteoblast-lineage cells in humans. N Engl J Med 352, 1959, 2005.
8. Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L.,Abramovitch, R., and Keshet, E. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175, 2006.
9. Jin, D.K., Shido, K., Kopp, H.G., Petit, I., Shmelkov, S.V., Young, L.M., Hooper, A.T., Amano, H., Avecilla, S.T., Heissig, B., Hattori, K., Zhang, F., Hicklin, D.J., Wu, Y., Zhu, Z., Dunn, A., Salari, H., Werb, Z., Hackett, N.R., Crystal, R.G., Lyden, D., and Rafii, S. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12, 557, 2006.
10. Karp, J.M., and Leng Teo, G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4, 206, 2009.
11. Kuznetsov, S.A., Mankani, M.H., Gronthos, S., Satomura, K., Bianco, P., and Robey, P.G. Circulating skeletal stem cells. J Cell Biol 153, 1133, 2001.
12. Wan, C., He, Q., and Li, G. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. J Orthop Res 24, 610, 2006.
13. Wragg, A., Mellad, J.A., Beltran, L.E., Konoplyannikov, M., San, H., Boozer, S., Deans, R.J., Mathur, A., Lederman, R.J., Kovacic, J.C., and Boehm, M. VEGFR1=CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med 86, 1221, 2008.
14. Zhou, B., Han, Z.C., Poon, M.C., and Pu, W. Mesenchymal stem=stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Med Hypotheses 68, 1268, 2007.
15. Zhu, W., Boachie-Adjei, O., Rawlins, B.A., Frenkel, B., Boskey, A.L., Ivashkiv, L.B., and Blobel, C.P. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem 282, 18676, 2007.
16. Tabata, Y. Significance of release technology in tissue engineering. Drug Discov Today 10, 1639, 2005.
17. Reddi, A.H. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 83-A Suppl 1, S1, 2001.
18. Wozney, J.M. Overview of bone morphogenetic proteins. Spine 27, S2, 2002.
19. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., and Wang, E.A. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528, 1988.
20. Bessa, P.C., Casal, M., and Reis, R.L. Bone morphogenetic proteins in tissue engineering: the road fromlaboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2, 81, 2008.
21. Otsuru, S., Tamai, K., Yamazaki, T., Yoshikawa, H., and Kaneda, Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 354, 453, 2007.
22. Bruder, S.P., Fink, D.J., and Caplan, A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56, 283, 1994.
23. Colnot, C., Huang, S., and Helms, J. Analyzing the cellular contribution of bone marrow to fracture healing using bone marrow transplantation in mice. Biochem Biophys Res Commun 350, 557, 2006.
24. Grundnes, O., and Reikeras, O. Effects of degrees of reaming on healing of segmental fractures in rats. J Orthop Trauma 12, 192, 1998.
25. Yamamoto, M., Takahashi, Y., and Tabata, Y. Controlled release by biodegradable hydrogyels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24, 4375, 2003.
26. Tabata, Y., Nagano, A., Muniruzzaman, M., and Ikada, Y. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials 19, 1781, 1998.
27. Ozeki, M., and Tabata, Y. In vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. J Biomater Sci Polym Ed 16, 549, 2005.
28. Otsuru, S., Tamai, K., Yamazaki, T., Yoshikawa, H., and Kaneda, Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4=stromal cell-derived factor-1 pathway. Stem Cells 26, 223, 2008.
29. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., and Nishimune, Y. Green mice as a source of ubiquitous green cells. FEBS Lett 407, 313, 1997.
30. Sotobori, T., Ueda, T., Myoui, A., Yoshioka, K., Nakasaki, M., Yoshikawa, H., and Itoh, K. Bone morphogenetic protein- 2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts. Exp Cell Res 312, 3927, 2006.
31. Wagner, T.U. Bone morphogenetic protein signaling in stem cells-one signal, many consequences. FEBS J 274, 2968, 2007.
32. Bessa, P.C., Pedro, A.J., Klosch, B., Nobre, A., van Griensven, M., Reis, R.L., and Casal, M. Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 produced in Escherichia coli. Biotechnol Lett 30, 15, 2008.
33. Deckers, M.M., van Bezooijen, R.L., van der Horst, G., Hoogendam, J., van Der Bent, C., Papapoulos, S.E., and Lowik, C.W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545, 2002.
34. Hay, E., Lemonnier, J., Fromigue, O., and Marie, P.J. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276, 29028, 2001.
35. Marrony, S., Bassilana, F., Seuwen, K., and Keller, H. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 33, 426, 2003.
36. Maes, C., Coenegrachts, L., Stockmans, I., Daci, E., Luttun, A., Petryk, A., Gopalakrishnan, R., Moermans, K., Smets, N., Verfaillie, C.M., Carmeliet, P., Bouillon, R., and Carmeliet, G. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 116, 1230, 2006.
37. Fiedler, J., Leucht, F., Waltenberger, J., Dehio, C., and Brenner, R.E. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334, 561, 2005.